{
    "code": "02025129",
    "time": "2015-06-22 01:03:40",
    "許可證字號": "衛署藥輸字第025129號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/12\/16",
    "發證日期": "98\/12\/16",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202512906",
    "中文品名": "拜瑞妥膜衣錠10毫克",
    "英文品名": "Xarelto film-coated tablets 10mg",
    "適應症": "1.用於非瓣膜性心房顫動(non-valvular atrial fibrillation)且有下列至少一項危險因子者成人病患，預防中風及全身性栓塞(systemic embolism)。危險因子例如:心衰竭、高血壓、年齡大於等於75歲、糖尿病、曾發生腦中風或短暫性腦缺血發作(transient ischemic attack)。\r\n2.Rivaroxaban用於靜脈血栓高危險群(曾發生有症狀之靜脈血栓症)病患，以預防其於接受下肢重大骨科手術後之靜脈血栓栓塞症(VTE)。",
    "劑型": "116膜衣錠",
    "包裝": "2~1000錠鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "RIVAROXABAN",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1426201100  臺灣拜耳股份有限公司",
    "申請商地址": "台北市信義區信義路五段7號台北101大樓之53至54樓",
    "主製造廠": {
        "製造廠名稱": "F470082000  BAYER PHARMA AG",
        "製造廠廠址": "D-51368 LEVERKUSEN GERMANY",
        "製造廠公司地址": "",
        "製造廠國別": "GERMANY",
        "製程": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200099500",
            "成分名稱": "RIVAROXABAN",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 Xarelto 10&15&20mg_122014_906x305mm-104-04-01.pdf Xarelto 10&15&20mg_906x305mm_092014-104-02-25.pdf 衛署藥輸字第025129號_Xarelto 10mg_012014-2014-07-28.pdf 拜瑞妥膜衣錠10&15&20mg_906x305mm-102-11-07.pdf 衛署藥輸字第025129號_仿單_012013___20130123.pdf 拜瑞妥膜衣錠10毫克_仿單___20120327.pdf Xarelto_仿單___20110714.pdf Xarelto 10mg - package insert.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025129&Seq=008&Type=9"
        },
        {
            "title": "外盒 Xarelto 10mg - foi.pdf Xarelto 10mg - carton.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025129&Seq=002&Type=8"
        }
    ]
}